The vast majority (93%) of the adverse events reports following Gardasil have been non-serious. Reports of non-serious adverse events after Gardasil vaccination have included fainting, pain and swelling at the injection site (the arm), headache, nausea and fever. Fainting is common after injections and vaccinations, especially in adolescents.
The proportion of subjects who permanently discontinued treatment due to adverse events was 4% for subjects receiving placebo, 1% for subjects receiving SOVALDI + ribavirin for 12 weeks, <1% for subjects receiving SOVALDI + ribavirin for 24 weeks, 11% for subjects receiving peginterferon alfa + ribavirin for 24 weeks and 2% for subjects receiving SOVALDI + peginterferon alfa + ribavirin for 12 weeks.
When they saw my left liver lope and right are super swollen and because I had an adverse event on the interferon the Mayo told me it would happen again. Plus I developed a blood plasma disorder called hypergammaglobunemia. They tell me that chemo can hurt normal livers and right now my liver enzymes are Alt 278, Ast 429 I don't qualify for a transplant because I have 2 blood disorders.
Concomitant use of Suboxone with other CNS depressants such as tramadol can lead to additive respiratory depression or a decrease in blood pressure. Serious adverse events including death may occur with concomitant use of a CNS/respiratory depressant(s) with buprenorphine. A dose reduction of one or both drugs may be warranted.
There can be some serious adverse effects (some of which are long-term). There is a process to report adverse events to the FDA but I do not know if they "accept" all reports. We do not get full disclosure of a lot of things medical so it seems that would also apply to vaccines. It is important that we do our research since we are the ones who have to live with the after effects. These links may be helpful in making this decision:
http://www.fda.
One subject developed an urticarial rash with no other physical findings, and was treated successfully with anti-histamine. Adverse events appear to have been randomly scattered across all six dosing groups with no apparent dose-related increases in occurrence rate or severity with the possible exception of mild lightheadedness. Both subjects with mild lightheadedness were in the 2 mg/kg group.
These things are tested with adverse events reported. They look for patterns of things that happen to people pre release of the drug to the public but then continue to report adverse events when it is used outside of clinical studies. I didn't really see this as a concern in the literature related to issues with the medication. https://www.webmd.com/drugs/2/drug-177765/tri-mix-papaverine-phentolamine-pge1-intracavernosal/details/list-sideeffects Did you yourself get a uti?
The most common adverse events in both treatment arms were fatigue, headache, nausea and insomnia. Two patients discontinued treatment due to adverse events.In genotype 1a patients with the Q80K polymorphism at baseline, 89 percent and 83 percent achieved SVR12 after 12 weeks of treatment with and without ribavirin, respectively. Rapid virologic response (RVR, defined as undetectable HCV RNA at Week 4 of treatment) was not found to be predictive of achieving SVR.
Then, 2 days ago (feb 2008) he blacked out and totalled his car. he was free of drugs and alcohol, and the only med he was on was celexa. I AM TERRIFIED!!! he is scared to go off the antidepressant, and I am scared for him to stay on them. can this be an adverse reaction. he HAD taken nyquil the night before his accident, but it had been about 15 hours.
In the randomized‚ double-blind‚ placebo-controlled trial of Neupogen® therapy following combination chemotherapy in patients (n = 207) with small cell lung cancer‚ the following adverse events were reported during blinded cycles of study medication (placebo or Neupogen® at 4 to 8 mcg/kg/day). Events are reported as exposure-adjusted since patients remained on double-blind Neupogen® a median of 3 cycles versus 1 cycle for placebo.
These include symptoms during or immediately after placement, such as mild to moderate cramping, nausea or vomiting, dizziness or lightheadedness, and bleeding or spotting.10 Additional adverse events can be explored by review of the Manufacturer and User Facility Device Experience database. This database is organized through the US FDA. Its utility is to represent reports of adverse events pertaining to various medical devices. The link to this website is http://www.accessdata.fda.
Recommended
